CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Use of a Tablet +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02758210
NCT02758210N/ACompleted
CompareCT.gov

Evaluating the Electro Magnetic Interference of Using Tablet and Smart Phone on Leadless Pacemaker (MICRA)

Emory University·interventional·Posted May 2, 2016·Updated Nov 9, 2017

In Brief

A clinical study evaluating Use of a Tablet and Use of a Smart Phone for Bradycardia, Atrial Tachyarrhythmia. Completed, enrolled 20 participants across 2 sites.

Detailed Summary

The purpose of this study is to evaluate the effects that electromagnetic field exposure from using a tablet and smart phone have on a leadless pacemaker (MICRA device).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBradycardia, Atrial Tachyarrhythmia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 2, 2016
Enrollment StartApr 1, 2016
Primary CompletionOct 24, 2016
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 10.2 years ago

Interventions

Use of a Tabletdevice

Testing of the electromagnetic field exposure and it's affect on the participant's previously implanted MICRA device is assessed by interrogation of the device before using Tablet and while using the Tablet. The measured position of the Tablets tested will be normal routine position (noting at least 6 inches/15 centimeters from their pacemaker).

Use of a Smart Phonedevice

Testing of the electromagnetic field exposure and it's affect on the participant's previously implanted MICRA device is assessed by interrogation of the device before using a Smart phone and while using the Smart phone. The position of the Smart phone tested will be normal position at the ear and while texting (noting at least 6 inches/15 centimeters from their pacemaker).